Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting - PubMed (original) (raw)
Review
. 2016 Apr 7;374(14):1356-67.
doi: 10.1056/NEJMra1515442.
Affiliations
- PMID: 27050207
- DOI: 10.1056/NEJMra1515442
Review
Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting
Rudolph M Navari et al. N Engl J Med. 2016.
No abstract available
Similar articles
- Efficacy of triplet regimen antiemetic therapy for chemotherapy-induced nausea and vomiting (CINV) in bone and soft tissue sarcoma patients receiving highly emetogenic chemotherapy, and an efficacy comparison of single-shot palonosetron and consecutive-day granisetron for CINV in a randomized, single-blinded crossover study.
Kimura H, Yamamoto N, Shirai T, Nishida H, Hayashi K, Tanzawa Y, Takeuchi A, Igarashi K, Inatani H, Shimozaki S, Kato T, Aoki Y, Higuchi T, Tsuchiya H. Kimura H, et al. Cancer Med. 2015 Mar;4(3):333-41. doi: 10.1002/cam4.373. Epub 2014 Dec 23. Cancer Med. 2015. PMID: 25533447 Free PMC article. Clinical Trial. - State of the Art Antiemetic Therapy for Cancer Patients.
Lau TK, Yip CH, Yeo W. Lau TK, et al. Curr Oncol Rep. 2016 Jan;18(1):2. doi: 10.1007/s11912-015-0486-5. Curr Oncol Rep. 2016. PMID: 26694923 Review. - 5-HT3 receptors as important mediators of nausea and vomiting due to chemotherapy.
Navari RM. Navari RM. Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2738-46. doi: 10.1016/j.bbamem.2015.03.020. Epub 2015 Mar 30. Biochim Biophys Acta. 2015. PMID: 25838122 - [Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J, Szántó J. Tóth J, et al. Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Magy Onkol. 2008. PMID: 19068468 Review. Hungarian. - Impact of 5-HT(3) RA selection within triple antiemetic regimens on uncontrolled highly emetogenic chemotherapy-induced nausea/vomiting.
Schwartzberg L, Jackson J, Jain G, Balu S, Buchner D. Schwartzberg L, et al. Expert Rev Pharmacoecon Outcomes Res. 2011 Aug;11(4):481-8. doi: 10.1586/erp.11.47. Epub 2011 Jun 28. Expert Rev Pharmacoecon Outcomes Res. 2011. PMID: 21711119
Cited by
- Neuroscience in peripheral cancers: tumors hijacking nerves and neuroimmune crosstalk.
Fan HY, Liang XH, Tang YL. Fan HY, et al. MedComm (2020). 2024 Oct 31;5(11):e784. doi: 10.1002/mco2.784. eCollection 2024 Nov. MedComm (2020). 2024. PMID: 39492832 Free PMC article. Review. - Dexamethasone-Sparing Antiemetic Prophylaxis for Chemotherapy-Induced Nausea and Vomiting in Highly and Moderately Emetogenic Chemotherapy: The SHEILD Study.
Reddy S, Kumar SB, Venkatesh T, Kumar Punukollu U, Sharma SB, Tripathi R. Reddy S, et al. Cureus. 2024 Sep 26;16(9):e70290. doi: 10.7759/cureus.70290. eCollection 2024 Sep. Cureus. 2024. PMID: 39463560 Free PMC article. - Establishing a nausea-free ward model to reduce chemotherapy-induced nausea and vomiting: A retrospective study.
Wang Y, Deng M, Huang Y, Liu L, Xiao Y, Hu L, Cao L, Wang Z, Yang Y. Wang Y, et al. Medicine (Baltimore). 2024 May 31;103(22):e38357. doi: 10.1097/MD.0000000000038357. Medicine (Baltimore). 2024. PMID: 39259117 Free PMC article. - Auriculotherapy and acupuncture treatments for chemotherapy-induced nausea and vomiting: a multicenter clinical trial.
Michel-Cherqui M, Ma S, Bacrie J, Huguet S, Lemaire N, Le Guen M, Fischler M. Michel-Cherqui M, et al. Support Care Cancer. 2024 Jul 31;32(8):560. doi: 10.1007/s00520-024-08768-w. Support Care Cancer. 2024. PMID: 39085664 Clinical Trial. - Differences in severity of chemotherapy-induced nausea and vomiting between neoadjuvant and adjuvant chemotherapy in patients with breast cancer: analysis of data from two prospective observational studies.
Son KL, Shin JS, Lee SH, Lee S, Jung S, Kim WH, Jung D, Kim TY, Im SA, Lee KH, Hahm BJ, Yeom CW. Son KL, et al. Support Care Cancer. 2024 Jul 13;32(8):511. doi: 10.1007/s00520-024-08718-6. Support Care Cancer. 2024. PMID: 39001910
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical